Secondary relevance to vitamin D This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.
This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.
Why this paper is included
Supporting source evidence:
Although the no-depression cohort initially exhibited a higher prevalence of all included comorbidities, after matching, only atrial fibrillation, anemia, and vitamin D deficiency remained significantly different.
Source: Baseline characteristics of patients. View original paper
Relevance classification does not establish study quality, causation or editorial approval.
Study design Cohort study.
Cohort study
Examines exposures and outcomes over time within a defined group.
Meta-analysis unclear · Blinding unclear / not reported · Human research reported
How this paper was classified
Automatic source-based classification; awaiting editorial verification. This is not a quality score.
A retrospective cohort study on the bidirectional association between depression and chronic kidney disease
Source: Article title.
Secondly, patients were excluded if they had a diagnosis of one of the top five most common cancers either prior to or within 10 years following their initial CKD diagnosis (: ).
Source: Methods.
What the study types mean
- Systematic review
- Uses explicit methods to identify, assess and summarise research on a defined question.
- Scoping review
- Maps the extent and characteristics of research on a topic.
- Narrative review
- Discusses existing research; systematic-review methods have not been established by this classification.
- Review / evidence synthesis
- Reviews existing research; the exact review methods need further assessment.
- Randomised controlled trial
- Assigns participants or groups to comparison interventions by chance.
- Non-randomised intervention study
- Examines an intervention without random allocation.
- Cohort study
- Examines exposures and outcomes over time within a defined group.
- Case-control study
- Compares people with an outcome against people without it, examining exposures.
- Cross-sectional study
- Examines a population at a particular point in time.
- Observational study
- Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
- Case report
- Describes an individual case.
- Case series
- Describes a group of individual cases.
- Secondary analysis
- Analyses existing study data; this paper is not automatically another independent trial.
- Laboratory study
- Investigates biological processes in a laboratory setting.
- Qualitative study
- Examines experiences or meanings using qualitative methods.
- Genetic instrumental-variable study
- Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
- Study protocol
- Describes planned methods and is not evidence that the planned study has reported results.
- Multiple reported designs
- More than one design is explicitly reported; examine the supporting methods.
- Study design awaiting verification
- The available source does not establish a sufficiently clear study design.
Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.
Abstracts
A retrospective cohort study on the bidirectional association between depression and chronic kidney disease
Cohort study · Frontiers in Nephrology · 2026
Original publication title
A retrospective cohort study on the bidirectional association between depression and chronic kidney disease
Copyright © 2026 Jeun, Brothers, Shawwa and Al-Mamun.
Original publication · Publisher record · CC BY 4.0
Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.
At a glance
Abstract: What methods does the paper describe?
This was a retrospective cohort analysis. Data was extracted from the TriNetX EMR database from 2007 to 2022. Patients (>18 years of age) with diagnosis of CKD were selected for the study. Key independent variables were diagnosis of depression or anxiety, identified by ICD codes, for the primary objective, and CKD stages (i.e., >3, 4, and 5) defined by KDIGO for the secondary objective. Primary outcome was progression to kidney disease (eGFR < 60 ml/min/bsa and > 40% decline in eGFR from the initial screening), and the secondary outcome was diagnosis of depression.
Kaplan-Meier analysis and Cox proportional hazards model were used to evaluate the relationship between the dependent and independent variables while adjusting for covariates (sex, race, ethnicity, and age).
Source: MethodsAbstract: Rationale and objectives
Depression has been associated with worse clinical outcomes in individuals with chronic kidney disease (CKD), yet its influence on kidney disease progression in earlier CKD stages remains underexplored. Thus, this study investigates the role of depression on CKD progression by stages, and bidirectional relationship using real-world data.
Source: Rationale and objectivesAbstract: Results
Depression was significantly associated with a higher risk of kidney disease progression (HR = 1.94 [1.77 to 2.11], p<0.001). Among patients with CKD, patients with CKD stages 4 and 5 had significantly higher risks (HR = 1.26 [1.17 to 1.35] and 1.38 [1.23 to 1.54], p<0.001) of new diagnosis of depression than those in stage ≤3, respectively. These associations remained statistically significant after matching and adjusting for age, sex, race, and comorbidities.
Source: ResultsAbstract: Conclusion
Depression significantly accelerates CKD progression and patients with stage 5 CKD had the highest risk of developing depression. Our study advocates for integrating frequent mental health screenings for patients with CKD. This could improve patient outcomes and minimize negative consequences associated with depression.
Source: ConclusionAuthors’ abstract
Rationale and objectives
Depression has been associated with worse clinical outcomes in individuals with chronic kidney disease (CKD), yet its influence on kidney disease progression in earlier CKD stages remains underexplored. Thus, this study investigates the role of depression on CKD progression by stages, and bidirectional relationship using real-world data.
Methods
This was a retrospective cohort analysis. Data was extracted from the TriNetX EMR database from 2007 to 2022. Patients (>18 years of age) with diagnosis of CKD were selected for the study. Key independent variables were diagnosis of depression or anxiety, identified by ICD codes, for the primary objective, and CKD stages (i.e., >3, 4, and 5) defined by KDIGO for the secondary objective. Primary outcome was progression to kidney disease (eGFR < 60 ml/min/bsa and > 40% decline in eGFR from the initial screening), and the secondary outcome was diagnosis of depression.
Kaplan-Meier analysis and Cox proportional hazards model were used to evaluate the relationship between the dependent and independent variables while adjusting for covariates (sex, race, ethnicity, and age).
Results
Depression was significantly associated with a higher risk of kidney disease progression (HR = 1.94 [1.77 to 2.11], p<0.001). Among patients with CKD, patients with CKD stages 4 and 5 had significantly higher risks (HR = 1.26 [1.17 to 1.35] and 1.38 [1.23 to 1.54], p<0.001) of new diagnosis of depression than those in stage ≤3, respectively. These associations remained statistically significant after matching and adjusting for age, sex, race, and comorbidities.
Conclusion
Depression significantly accelerates CKD progression and patients with stage 5 CKD had the highest risk of developing depression. Our study advocates for integrating frequent mental health screenings for patients with CKD. This could improve patient outcomes and minimize negative consequences associated with depression.
Publication and source details
Original title: A retrospective cohort study on the bidirectional association between depression and chronic kidney disease
Ki Jin Jeun; Todd Brothers; Khaled Shawwa; Mohammad A. Al-Mamun
Frontiers in Nephrology · 2026
* Correspondence: Todd Brothers, tbrothers@uri.edu; Mohammad A. Al-Mamun, mohammad.almamun@hsc.wvu.eduCopyright © 2026 Jeun, Brothers, Shawwa and Al-Mamun.2026Jeun, Brothers, Shawwa and Al-Mamunhttps://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. U.S. National Library of Medicine10.13039/100000092 The author(s) declared that financial support was received for this work and/or its publication. This study has been funded by the Network of the National Library of Medicine (NNLM).Grant no: 1UG4LM013724-02.Repository JATS snapshot; version as supplied
Source retrieved: 2026-11-11T00:40:18.510524+00:00
DOI: 10.3389/fneph.2025.1743594 · PMC12812636